Device typeMethotrexate therapeutic drug monitoring IVD, kit, enzyme immunoassay (EIA): A collection of reagents and other associated materials intended to be used for the quantitative measurement and therapeutic monitoring of the antineoplastic drug methotrexate in a clinical specimen, using an enzyme immunoassay (EIA) method.
FDA categoryEnzyme Immunoassay, Methotrexate
Device ID00812101031162
Catalog number5071-0001-00
AvailabilityPrescription
MRI safetyLabeling does not contain MRI Safety Information